ANTI-HSA-ANTIKÖRPER

Patent europeic · EP3634997 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3634997
Numer da la dumonda
EP18729642
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
04-06-2018
Publitgà
15-04-2020
Concedì
26-02-2025
La protecziun finescha il pli tard
03-06-2038
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07K 16/18 (2006.01)
C07K 16/24 (2006.01)
Prioritad
US 201762515293 P 05.06.2017
EP 17195783 10.10.2017
Dumonda PCT
PCT/EP2018/064622 04.06.2018
Publicaziun PCT
WO2018/224439 13.12.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 07-01-2026

    Midada

    Published in Swissreg on 07.01.2026

  3. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. 05-03-2025

    Owner

    Owner
    Numab Therapeutics AG, Einsiedlerstrasse 34, 8820 Wädenswil → Numab Therapeutics AG, Bachtobelstrasse 5, 8810 Horgen

    Published in Swissreg on 05.03.2025

  5. 05-03-2025

    Midada

    Published in Swissreg on 05.03.2025

  6. 26-02-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.02.2025

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.